A case of myocardial infarction with sumatriptan use
E Erbilen1, H Ozhan, R Akdemir
1Department of Cardiology, Faculty of Medicine, Abant Izzet Baysal University Düzce, Kardiyoloji Kliniği, Konuralp, Turkey.
Pediatric Cardiology
|December 24, 2005
Summary
Sumatriptan, a common cluster headache medication, may be linked to heart attacks. A teenage patient experienced myocardial infarction after using sumatriptan despite having no heart disease risk factors.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Sumatriptan is a first-line treatment for acute cluster headache attacks.
- It functions as a serotonin-1 (5HT-1) receptor agonist.
- Previous research suggests a potential link between sumatriptan and myocardial infarction due to its vasoconstrictive effects.
Observation:
- A 16-year-old male presented with symptoms of acute inferior myocardial infarction.
- The patient had recently used sumatriptan for cluster headache treatment.
- No conventional risk factors for coronary artery disease were identified in the patient.
Findings:
- The case highlights a potential adverse cardiovascular event associated with sumatriptan use.
- Myocardial infarction occurred in an adolescent without pre-existing cardiovascular risk factors.
- This suggests sumatriptan may precipitate cardiac events even in young, otherwise healthy individuals.
Implications:
- Clinicians should consider sumatriptan's potential cardiovascular risks, especially in younger populations.
- Further investigation into the mechanisms linking sumatriptan to myocardial infarction is warranted.
- This case underscores the importance of thorough patient evaluation for cardiovascular risk before prescribing vasoconstrictive migraine medications.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...